Company profile · Uppsala, Sweden

Biovica

Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays · Commercial diagnostics platform

Biovica runs cancer monitoring, biomarker assays, and oncology diagnostics in Uppsala, Sweden.

Lead
Anders Rylander (verified ↗)
Address
Dag Hammarskjolds vag 54A, 752 37 Uppsala, Sweden (source ↗)
Compliance
Not yet on record
Last reviewed
21 Mar 2026 (2mo ago)
Scale
Commercial diagnostics platform
Capabilities
Cancer Monitoring · Biomarker Assays · Oncology Diagnostics
Founded
2006
Headcount
11-50
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Anders Rylander

CEO

Check official leadership source
Full addressDag Hammarskjolds vag 54A, 752 37 Uppsala, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Biovica contact page listing the Uppsala address.

Open source
Operating profile

Commercial diagnostics platform

Uppsala, Sweden. Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays. Review completed on 21 Mar 2026.

2026 technical specializationCancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays
Core capabilities
Cancer MonitoringBiomarker AssaysOncology Diagnostics
Governance

Swedish corporate and diagnostics oversight

Official leadership disclosure, Official Uppsala contact disclosure, Oncology diagnostics platform claim

Editorial note

Cancer Monitoring, Biomarker Diagnostics, Blood-Based Testing, and Oncology Assays

Biovica is published because official company materials confirm current leadership, Uppsala operating address, and a real oncology diagnostics platform.

Editorial note

Biovica is published because official company materials confirm current leadership, Uppsala operating address, and a real oncology diagnostics platform.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 21 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Cancer Monitoring
Biomarker Assays
Oncology Diagnostics
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial Biovica materials naming Anders Rylander as CEO.Source origin: biovica.comOpen source
Supporting evidenceOfficial Biovica site describing the DiviTum cancer-monitoring diagnostics platform.Source origin: biovica.comOpen source
Physical-site evidenceOfficial Biovica contact page listing the Uppsala address.Source origin: biovica.comOpen source
Infrastructure

Declared infrastructure

Biomarker testing workflow
Cancer-monitoring platform
Diagnostics development systems
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Biovica located?
Biovica operates from Dag Hammarskjolds vag 54A, 752 37 Uppsala, Sweden, Uppsala, Sweden.
Who runs Biovica?
Biovica is led by Anders Rylander, CEO. Verified 21 Mar 2026.
What does Biovica do?
Biovica runs cancer monitoring, biomarker assays, and oncology diagnostics in Uppsala, Sweden. Core capabilities: Cancer Monitoring, Biomarker Assays, Oncology Diagnostics.
Editorial context

Related technical briefs

Briefs that name Uppsala as a covered market or city.